Retatrutide — The Metabolic Peptide
- Supports weight reduction
- Supports glycaemic control
- Reduces hepatic fat
Overview
This product is supplied as a kit, not as a pre-filled cartridge. Everything needed to prepare a pen cartridge is included — the powder is shipped sealed and lyophilised, and is reconstituted by you at the point of use rather than by us before dispatch.
A reconstituted cartridge is a liquid preparation with a limited stable life, and transit conditions cannot be controlled. Supplying the compound dry removes that variable entirely: the material arrives in the state it was tested in, and the clock only starts when you mix it. Available in 20mg, 40mg and 60mg.
What’s in the kit
- Retatrutide powder — lyophilised, sealed: one 20mg or one 40mg vial as selected, or a 20mg and a 40mg vial together for the 60mg kit
- 1 × bacteriostatic water, 3ml — for reconstitution
- 1 × pen cartridge — empty, ready to fill
- 1 × insulin needle
The cartridge fits our peptide pens. Our reconstitution calculator will work out the concentration and draw volume for the water volume you use.
Key Specifications
- Product format: Unmixed kit — powder vial, diluent, cartridge and needle
- Available sizes: 20mg, 40mg and 60mg
- Source compound: Retatrutide — also available as a lyophilised powder vial
- Purity: Verified by HPLC on every batch — the measured figure for your lot is published on its certificate of analysis
- Preparation: Supplied dry; reconstituted by you at the point of use
- Storage: Store the sealed vial cool, dry and away from light. Refrigerate once reconstituted
- Dispatch: Within 48 hours — each kit is assembled to order
- Intended use: Laboratory research use only
Research Focus
Retatrutide is a triple agonist, acting on the GLP-1, GIP and glucagon receptors simultaneously where earlier compounds in its class targeted one or two. Published Phase 2 trial results have examined body-weight reduction, glycaemic control and hepatic fat content, with the triple-receptor mechanism reported to produce greater effect than single or dual agonists. Phase 3 trials are ongoing.
Retatrutide has been studied in human clinical trials. Our summary of the published literature is here: Retatrutide Dosage: What Studies Have Investigated.
Testing & Certificates of Analysis
Kits contain the same independently tested powder as our standalone vials — HPLC purity and mass-spectrometry identity, certified per batch and published on our lab results page.
Returns
Kits are assembled to order. An unopened kit with all seals intact can be returned within 14 days — but once the vial, water or needle seal has been broken it cannot be accepted back on hygiene grounds, and anything already reconstituted cannot be returned. Faulty, damaged or incorrect items are always put right. See our refund policy.
For laboratory research use only. All products sold by USPeptidesCo are strictly for laboratory research purposes and are not intended for human or veterinary consumption. No dosing, administration or physiological guidance is provided.

Reviews
There are no reviews yet.